BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Knight Therapeutics
Knight TherapeuticsQC - Montréal
1 program
Biospecimen CollectionN/A1 trial
Active Trials
NCT04494945Recruiting27,500Est. Mar 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Knight TherapeuticsBiospecimen Collection

Clinical Trials (1)

Total enrollment: 27,500 patients across 1 trials

NCT04494945Knight TherapeuticsBiospecimen Collection

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Start: Mar 2020Est. completion: Mar 202627,500 patients
N/ARecruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 27,500 patients
1 companies competing in this space